Physician profile
Lori Medeiros
NPI 1720017353
$6,832.57
in general payments reported to CMS, 2019-2025
9 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,871 · 2020: $400 · 2023: $211 · 2024: $173 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $5,002.85 | 2019 | |
| Carl Zeiss Meditec, INC. | $1,268.14 | 2019-2020 | |
| Dilon Technologies, INC. | $178.06 | 2025 | Hemoblast Bellows |
| Siemens Medical Solutions USA, INC. | $151.31 | 2023 | Truebeam |
| Myriad Genetic Laboratories, INC. | $122.84 | 2023-2024 | Myrisk |
| Hologic Sales and Service, LLC | $59.71 | 2024 | Localizer |
| Elucent Medical | $25.25 | 2024 | |
| Tactile Systems Technology INC | $20.55 | 2023 | Entre Plus, Flexitouch Plus |
| Musculoskeletal Transplant Foundation INC. | $3.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Medeiros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.